Welcome!

News Feed Item

Taconic and CERBM-IGBMC Collaborate to Offer Cre-ERT Technology for Inducible Gene Targeting in Genetically Modified Rodents

HUDSON, NY -- (Marketwired) -- 07/10/14 -- Taconic and Le Centre Européen de Recherche en Biologie et en Médecine - Institut de Génétique et de Biologie Moléculaire et Cellulaire (CERBM-IGBMC) today announced a global cross-licensing agreement to improve access to Cre-ERT technology for inducible gene targeting in genetically engineered rodents. Under the agreement each party will be able to generate, sell and use Cre-ERT mouse lines for Tamoxifen induction experiments. Further, Taconic will play a role in helping companies acquire needed rights from CERBM-IGBMC to perform induction studies in Cre-ERT gene targeted mouse lines. Taconic and CERBM-IGBMC are the only fully licensed service providers of the Cre-ERT technology. Combining the access rights to both patent families is specifically important because it equips researchers to explore gene function in adult mice.

Cre-ERT technology was developed independently by scientists at two organizations: Francis Stewart at the European Molecular Biology Laboratory (EMBL) as well as Pierre Chambon and Daniel Metzger at the CERBM-IGBMC. Taconic is the exclusive commercial license holder of the EMBL patent portfolio broadly covering the use of ligand-dependent site-specific recombinases. The CERBM-IGBMC patents cover methods for performing inducible gene targeting in transgenic mice expressing a Cre-ERT fusion protein. The method employs administration of Tamoxifen to transgenic mice to induce Cre-mediated recombination.

The agreement by Taconic and CERBM-IGBMC to further develop and provide access to Cre-ERT technology addresses key challenges relating to understanding cancer, metabolic disorders, stroke and other diseases. "We are very pleased to partner with CERBM-IGBMC to further develop the effective application of Cre-ERT technology in genetically engineered mouse models," stated Todd Little, President of Taconic. "Cre-ERT technology is a powerful tool for studying gene function and expression in many tissues."

The agreement also enhances both organizations' efforts to bring better, more predictive mouse models to market for use by scientists worldwide. "We have greatly contributed to the development and success of the 'Cre-ERT' technology, and will continue to make it freely available to the academic scientific community," said Professor Chambon at the CERBM-IGBMC. "We are very happy with this agreement, and hope that it will contribute to the generation of several new mouse models of human diseases for use in drug discovery and development," said Dr. Daniel Metzger at the CERBM-IGBMC.

About Taconic
Taconic is a global provider of genetically engineered mouse and rat models and services. As a full-service industry leader, founded in 1952, Taconic helps clients acquire, test, develop, breed, cryopreserve, prepare, and distribute highly relevant research lines worldwide. Headquartered in New York's Hudson River Valley, Taconic operates six breeding facilities and three service laboratories in the U.S. and Europe and maintains over 850 employees committed to technological innovation. Taconic's products and services are used by over 1300 companies and academic research institutions in nearly 50 nations worldwide. Learn more at http://www.taconic.com

About the Centre Européen en Biology et Médecine (CERBM) and the Institute of Genetics and Molecular and Cellular Biology (IGBMC).
The Institute of Genetics and Molecular and Cellular Biology (IGBMC) which was created in 1994 by Pierre Chambon is one of the main European centers of biomedical research that combines, within the CERBM-IGBMC, Units of the INSERM, the CNRS and the University of Strasbourg. Besides four scientific departments, the CERBM-IGBMC includes scientific services and advanced technological platforms, such as the Mouse Clinical Institute (ICS), which are also open to the external scientific community. The objective of the CERBM-IGBMC is to develop multidisciplinary research interfacing biology, genetics, biochemistry, physics and medicine, and also to attract students and post-doctoral fellows from all around the world by offering high-level training in the field of biomedical sciences.

About the Cre-ERT technology
Cre-ERT technology is based on an enzyme called Cre recombinase. This enzyme is able to recombine specific sequences of DNA called loxP. Upon encountering two separate loxP sites flanking a target nucleotide sequence, Cre recombinase deletes this intervening sequence by an irreversible recombination event between the loxP sites. By excision of a loxP flanked (floxed) critical region of a gene, the gene can be conditionally knocked out only after Cre is expressed. The spatial control of the conditional knock-out can be achieved by driving Cre activity under a tissue-specific promoter in transgenic mice. In order to generate an inducible knock-out, the Cre enzyme has been fused to a mutated ligand-binding domain of the human estrogen receptor (ERT). Upon the introduction of the synthetic estrogen receptor antagonist tamoxifen, the Cre-ERT construct enters the nucleus and induces the targeted mutation. ERT binds tamoxifen but not to endogenous estrogens, which allows Cre-ERT to remain cytoplasmic in animals that are not treated with tamoxifen. The temporal control by tamoxifen permits to study gene function at the desired time. This can help to elucidate the gene function in adults which is important for drug discovery and basic research.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Big Data, cloud, analytics, contextual information, wearable tech, sensors, mobility, and WebRTC: together, these advances have created a perfect storm of technologies that are disrupting and transforming classic communications models and ecosystems. In his session at @ThingsExpo, Erik Perotti, Senior Manager of New Ventures on Plantronics’ Innovation team, provided an overview of this technological shift, including associated business and consumer communications impacts, and opportunities it ...
Cloud analytics is dramatically altering business intelligence. Some businesses will capitalize on these promising new technologies and gain key insights that’ll help them gain competitive advantage. And others won’t. Whether you’re a business leader, an IT manager, or an analyst, we want to help you and the people you need to influence with a free copy of “Cloud Analytics for Dummies,” the essential guide to this explosive new space for business intelligence.
You think you know what’s in your data. But do you? Most organizations are now aware of the business intelligence represented by their data. Data science stands to take this to a level you never thought of – literally. The techniques of data science, when used with the capabilities of Big Data technologies, can make connections you had not yet imagined, helping you discover new insights and ask new questions of your data. In his session at @ThingsExpo, Sarbjit Sarkaria, data science team lead ...
WebRTC is bringing significant change to the communications landscape that will bridge the worlds of web and telephony, making the Internet the new standard for communications. Cloud9 took the road less traveled and used WebRTC to create a downloadable enterprise-grade communications platform that is changing the communication dynamic in the financial sector. In his session at @ThingsExpo, Leo Papadopoulos, CTO of Cloud9, discussed the importance of WebRTC and how it enables companies to focus...
Qosmos has announced new milestones in the detection of encrypted traffic and in protocol signature coverage. Qosmos latest software can accurately classify traffic encrypted with SSL/TLS (e.g., Google, Facebook, WhatsApp), P2P traffic (e.g., BitTorrent, MuTorrent, Vuze), and Skype, while preserving the privacy of communication content. These new classification techniques mean that traffic optimization, policy enforcement, and user experience are largely unaffected by encryption. In respect wit...
ReadyTalk has expanded the capabilities of the FoxDen collaboration platform announced late last year to include FoxDen Connect, an in-room video collaboration experience that launches with a single touch. With FoxDen Connect, users can now not only engage in HD video conferencing between iOS and Android mobile devices or Chrome browsers, but also set up in-person meeting rooms for video interactions. A host’s mobile device automatically recognizes the presence of a meeting room via beacon tech...
Manufacturers are embracing the Industrial Internet the same way consumers are leveraging Fitbits – to improve overall health and wellness. Both can provide consistent measurement, visibility, and suggest performance improvements customized to help reach goals. Fitbit users can view real-time data and make adjustments to increase their activity. In his session at @ThingsExpo, Mark Bernardo Professional Services Leader, Americas, at GE Digital, discussed how leveraging the Industrial Internet a...
On Dice.com, the number of job postings asking for skill in Amazon Web Services increased 76 percent between June 2015 and June 2016. Salesforce.com saw its own skill mentions increase 37 percent, while DevOps and Cloud rose 35 percent and 28 percent, respectively. Even as they expand their presence in the cloud, companies are also looking for tech professionals who can manage projects, crunch data, and figure out how to make systems run more autonomously. Mentions of ‘data science’ as a skill ...
In his session at Cloud Expo, Robert Cohen, an economist and senior fellow at the Economic Strategy Institute, will provide economic scenarios that describe how the rapid adoption of software-defined everything including cloud services, SDDC and open networking will change GDP, industry growth, productivity and jobs. This session will also include a drill down for several industries such as finance, social media, cloud service providers and pharmaceuticals.
IoT generates lots of temporal data. But how do you unlock its value? You need to discover patterns that are repeatable in vast quantities of data, understand their meaning, and implement scalable monitoring across multiple data streams in order to monetize the discoveries and insights. Motif discovery and deep learning platforms are emerging to visualize sensor data, to search for patterns and to build application that can monitor real time streams efficiently. In his session at @ThingsExpo, ...
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.
"delaPlex is a software development company. We do team-based outsourcing development," explained Mark Rivers, COO and Co-founder of delaPlex Software, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Ixia (Nasdaq: XXIA) has announced that NoviFlow Inc.has deployed IxNetwork® to validate the company’s designs and accelerate the delivery of its proven, reliable products. Based in Montréal, NoviFlow Inc. supports network carriers, hyperscale data center operators, and enterprises seeking greater network control and flexibility, network scalability, and the capacity to handle extremely large numbers of flows, while maintaining maximum network performance. To meet these requirements, NoviFlow in...
Choosing the right cloud for your workloads is a balancing act that can cost your organization time, money and aggravation - unless you get it right the first time. Economics, speed, performance, accessibility, administrative needs and security all play a vital role in dictating your approach to the cloud. Without knowing the right questions to ask, you could wind up paying for capacity you'll never need or underestimating the resources required to run your applications.
Ovum, a leading technology analyst firm, has published an in-depth report, Ovum Decision Matrix: Selecting a DevOps Release Management Solution, 2016–17. The report focuses on the automation aspects of DevOps, Release Management and compares solutions from the leading vendors.